247 related articles for article (PubMed ID: 30104869)
21. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
[TBL] [Abstract][Full Text] [Related]
22. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
F1000Res; 2023; 12():528. PubMed ID: 37928173
[No Abstract] [Full Text] [Related]
23. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
24. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
[TBL] [Abstract][Full Text] [Related]
25. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
[TBL] [Abstract][Full Text] [Related]
26. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
[TBL] [Abstract][Full Text] [Related]
27. Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients.
Tangedal S; Aanerud M; Grønseth R; Drengenes C; Wiker HG; Bakke PS; Eagan TM
Respir Res; 2017 Aug; 18(1):164. PubMed ID: 28851370
[TBL] [Abstract][Full Text] [Related]
28. Analysis of microbiota in stable patients with chronic obstructive pulmonary disease.
Aguirre E; Galiana A; Mira A; Guardiola R; Sánchez-Guillén L; Garcia-Pachon E; Santibañez M; Royo G; Rodríguez JC
APMIS; 2015 May; 123(5):427-32. PubMed ID: 25858184
[TBL] [Abstract][Full Text] [Related]
29. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
Wu Y; Luo Z; Liu C
Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
[TBL] [Abstract][Full Text] [Related]
30. Seasonal Dynamics of the Upper Respiratory Tract Microbiome in Chronic Obstructive Pulmonary Disease.
Cai S; Gao J; Liu X; Yang J; Feng D; Li G; Li S; Yang H; Wang Z; Yi X; Zhou Y
Int J Chron Obstruct Pulmon Dis; 2023; 18():1267-1276. PubMed ID: 37362620
[TBL] [Abstract][Full Text] [Related]
31. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
[TBL] [Abstract][Full Text] [Related]
32. Saliva as a non-invasive specimen for COPD assessment.
Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
[TBL] [Abstract][Full Text] [Related]
33. Characterization of throat microbial flora in smokers with or without COPD.
Diao W; Shen N; Du Y; Qian K; He B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1933-1946. PubMed ID: 28740374
[TBL] [Abstract][Full Text] [Related]
34. The sputum microbiome is distinct between COPD and health, independent of smoking history.
Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.
Dicker AJ; Crichton ML; Pumphrey EG; Cassidy AJ; Suarez-Cuartin G; Sibila O; Furrie E; Fong CJ; Ibrahim W; Brady G; Einarsson GG; Elborn JS; Schembri S; Marshall SE; Palmer CNA; Chalmers JD
J Allergy Clin Immunol; 2018 Jan; 141(1):117-127. PubMed ID: 28506850
[TBL] [Abstract][Full Text] [Related]
36. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.
Millares L; Ferrari R; Gallego M; Garcia-Nuñez M; Pérez-Brocal V; Espasa M; Pomares X; Monton C; Moya A; Monsó E
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1101-11. PubMed ID: 24449346
[TBL] [Abstract][Full Text] [Related]
37. Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes.
Ramsheh MY; Haldar K; Bafadhel M; George L; Free RC; John C; Reeve NF; Ziegler-Heitbrock L; Gut I; Singh D; Mistry V; Tobin MD; Oggioni MR; Brightling C; Barer MR
Thorax; 2020 Jan; 75(1):8-16. PubMed ID: 31699806
[TBL] [Abstract][Full Text] [Related]
38. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
Xiao W; Du LY; Mao B; Miao TW; Fu JJ
BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
[TBL] [Abstract][Full Text] [Related]
39. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
[TBL] [Abstract][Full Text] [Related]
40. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
